New drugs in acute myeloid leukemia #MMPMID26802152
Kadia TM; Ravandi F; Cortes J; Kantarjian H
Ann Oncol 2016[May]; 27 (5): 770-8 PMID26802152show ga
Standard treatment for acute myeloid leukemia has changed little in the past 40 years. New cytotoxic agents, targeted small-molecule inhibitors, and monoclonal antibodies are currently in advanced development to improve on standard approaches.